| UniProt ID | SCFD1_HUMAN | |
|---|---|---|
| UniProt AC | Q8WVM8 | |
| Protein Name | Sec1 family domain-containing protein 1 | |
| Gene Name | SCFD1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 642 | |
| Subcellular Localization |
Cytoplasm. Endoplasmic reticulum membrane Peripheral membrane protein. Golgi apparatus, Golgi stack membrane Peripheral membrane protein. |
|
| Protein Description | Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with COG4. Involved in vesicular transport between the endoplasmic reticulum and the Golgi (By similarity).. | |
| Protein Sequence | MAAAAAATAAAAASIRERQTVALKRMLNFNVPHIKNSTGEPVWKVLIYDRFGQDIISPLLSVKELRDMGITLHLLLHSDRDPIPDVPAVYFVMPTEENIDRMCQDLRNQLYESYYLNFISAISRSKLEDIANAALAASAVTQVAKVFDQYLNFITLEDDMFVLCNQNKELVSYRAINRPDITDTEMETVMDTIVDSLFCFFVTLGAVPIIRCSRGTAAEMVAVKLDKKLRENLRDARNSLFTGDTLGAGQFSFQRPLLVLVDRNIDLATPLHHTWTYQALVHDVLDFHLNRVNLEESSGVENSPAGARPKRKNKKSYDLTPVDKFWQKHKGSPFPEVAESVQQELESYRAQEDEVKRLKSIMGLEGEDEGAISMLSDNTAKLTSAVSSLPELLEKKRLIDLHTNVATAVLEHIKARKLDVYFEYEEKIMSKTTLDKSLLDIISDPDAGTPEDKMRLFLIYYISTQQAPSEADLEQYKKALTDAGCNLNPLQYIKQWKAFTKMASAPASYGSTTTKPMGLLSRVMNTGSQFVMEGVKNLVLKQQNLPVTRILDNLMEMKSNPETDDYRYFDPKMLRGNDSSVPRNKNPFQEAIVFVVGGGNYIEYQNLVDYIKGKQGKHILYGCSELFNATQFIKQLSQLGQK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAAAAATA ------CHHHHHHHH | 13.05 | 19413330 | |
| 14 | Phosphorylation | ATAAAAASIRERQTV HHHHHHHHHHHHHHH | 19.90 | 28464451 | |
| 24 | Methylation | ERQTVALKRMLNFNV HHHHHHHHHHHCCCC | 26.48 | 115977587 | |
| 24 | 2-Hydroxyisobutyrylation | ERQTVALKRMLNFNV HHHHHHHHHHHCCCC | 26.48 | - | |
| 37 | Phosphorylation | NVPHIKNSTGEPVWK CCCCCCCCCCCEEEE | 32.55 | - | |
| 57 | Phosphorylation | RFGQDIISPLLSVKE CCCCCCHHHHCCHHH | 15.16 | 19060867 | |
| 61 | Phosphorylation | DIISPLLSVKELRDM CCHHHHCCHHHHHHC | 38.53 | 24719451 | |
| 63 | Ubiquitination | ISPLLSVKELRDMGI HHHHCCHHHHHHCCC | 47.88 | 21890473 | |
| 113 | Phosphorylation | LRNQLYESYYLNFIS HHHHHHHHHHHHHHH | 12.91 | - | |
| 114 | Phosphorylation | RNQLYESYYLNFISA HHHHHHHHHHHHHHH | 10.47 | - | |
| 115 | Phosphorylation | NQLYESYYLNFISAI HHHHHHHHHHHHHHH | 12.40 | - | |
| 125 | Phosphorylation | FISAISRSKLEDIAN HHHHHCHHHHHHHHH | 34.50 | 25278378 | |
| 126 | Ubiquitination | ISAISRSKLEDIANA HHHHCHHHHHHHHHH | 55.58 | 21906983 | |
| 138 | O-linked_Glycosylation | ANAALAASAVTQVAK HHHHHHHHHHHHHHH | 20.05 | 28510447 | |
| 138 | Phosphorylation | ANAALAASAVTQVAK HHHHHHHHHHHHHHH | 20.05 | 25278378 | |
| 141 | O-linked_Glycosylation | ALAASAVTQVAKVFD HHHHHHHHHHHHHHH | 19.62 | 28510447 | |
| 141 | Phosphorylation | ALAASAVTQVAKVFD HHHHHHHHHHHHHHH | 19.62 | 25278378 | |
| 220 | Sulfoxidation | SRGTAAEMVAVKLDK CCCCHHHHHHHHHCH | 1.69 | 21406390 | |
| 252 | Phosphorylation | TLGAGQFSFQRPLLV CCCCCCCCCCCCEEE | 16.75 | 25627689 | |
| 257 | Ubiquitination | QFSFQRPLLVLVDRN CCCCCCCEEEEEECC | 5.86 | 21890473 | |
| 257 | Ubiquitination | QFSFQRPLLVLVDRN CCCCCCCEEEEEECC | 5.86 | 21890473 | |
| 297 | Phosphorylation | NRVNLEESSGVENSP HCCCCHHHCCCCCCC | 24.02 | 29255136 | |
| 298 | Phosphorylation | RVNLEESSGVENSPA CCCCHHHCCCCCCCC | 50.57 | 29255136 | |
| 303 | Phosphorylation | ESSGVENSPAGARPK HHCCCCCCCCCCCCC | 11.56 | 19664994 | |
| 315 | Malonylation | RPKRKNKKSYDLTPV CCCCCCCCCCCCCCH | 64.74 | 26320211 | |
| 315 | Ubiquitination | RPKRKNKKSYDLTPV CCCCCCCCCCCCCCH | 64.74 | - | |
| 316 | Phosphorylation | PKRKNKKSYDLTPVD CCCCCCCCCCCCCHH | 26.03 | 28355574 | |
| 317 | Phosphorylation | KRKNKKSYDLTPVDK CCCCCCCCCCCCHHH | 24.69 | 23403867 | |
| 320 | Phosphorylation | NKKSYDLTPVDKFWQ CCCCCCCCCHHHHHH | 20.54 | 21815630 | |
| 324 | Acetylation | YDLTPVDKFWQKHKG CCCCCHHHHHHHHCC | 49.05 | 21466224 | |
| 324 | Ubiquitination | YDLTPVDKFWQKHKG CCCCCHHHHHHHHCC | 49.05 | 21890473 | |
| 328 | Acetylation | PVDKFWQKHKGSPFP CHHHHHHHHCCCCCH | 37.57 | 21466224 | |
| 330 | Ubiquitination | DKFWQKHKGSPFPEV HHHHHHHCCCCCHHH | 69.03 | - | |
| 330 | Acetylation | DKFWQKHKGSPFPEV HHHHHHHCCCCCHHH | 69.03 | 21466224 | |
| 332 | Phosphorylation | FWQKHKGSPFPEVAE HHHHHCCCCCHHHHH | 28.33 | 21712546 | |
| 360 | Phosphorylation | DEVKRLKSIMGLEGE HHHHHHHHHHCCCCC | 23.54 | 28348404 | |
| 362 | Sulfoxidation | VKRLKSIMGLEGEDE HHHHHHHHCCCCCCH | 6.91 | 21406390 | |
| 373 | Phosphorylation | GEDEGAISMLSDNTA CCCHHHHHHCCCCHH | 17.09 | 27251275 | |
| 376 | Phosphorylation | EGAISMLSDNTAKLT HHHHHHCCCCHHHHH | 21.85 | 27251275 | |
| 379 | Phosphorylation | ISMLSDNTAKLTSAV HHHCCCCHHHHHHHH | 30.11 | - | |
| 383 | Phosphorylation | SDNTAKLTSAVSSLP CCCHHHHHHHHHCHH | 17.59 | 25850435 | |
| 384 | Phosphorylation | DNTAKLTSAVSSLPE CCHHHHHHHHHCHHH | 36.79 | 28348404 | |
| 387 | Phosphorylation | AKLTSAVSSLPELLE HHHHHHHHCHHHHHH | 26.35 | 25850435 | |
| 388 | Phosphorylation | KLTSAVSSLPELLEK HHHHHHHCHHHHHHH | 41.15 | 25850435 | |
| 395 | Ubiquitination | SLPELLEKKRLIDLH CHHHHHHHCCCHHCH | 43.07 | 21906983 | |
| 396 | Ubiquitination | LPELLEKKRLIDLHT HHHHHHHCCCHHCHH | 42.96 | - | |
| 417 | Ubiquitination | LEHIKARKLDVYFEY HHHHHHCCCEEEEEE | 54.63 | - | |
| 427 | Ubiquitination | VYFEYEEKIMSKTTL EEEEEHHHHCCCCCC | 31.59 | 21890473 | |
| 427 | Ubiquitination | VYFEYEEKIMSKTTL EEEEEHHHHCCCCCC | 31.59 | 21890473 | |
| 427 | Ubiquitination | VYFEYEEKIMSKTTL EEEEEHHHHCCCCCC | 31.59 | - | |
| 431 | Ubiquitination | YEEKIMSKTTLDKSL EHHHHCCCCCCCHHH | 28.31 | - | |
| 434 | Ubiquitination | KIMSKTTLDKSLLDI HHCCCCCCCHHHHHH | 10.65 | 21890473 | |
| 434 | Ubiquitination | KIMSKTTLDKSLLDI HHCCCCCCCHHHHHH | 10.65 | 21890473 | |
| 436 | Ubiquitination | MSKTTLDKSLLDIIS CCCCCCCHHHHHHHC | 46.22 | 21906983 | |
| 443 | Phosphorylation | KSLLDIISDPDAGTP HHHHHHHCCCCCCCH | 43.34 | - | |
| 494 | Ubiquitination | LNPLQYIKQWKAFTK CCHHHHHHHHHHHHH | 45.21 | 21906983 | |
| 500 | Phosphorylation | IKQWKAFTKMASAPA HHHHHHHHHHHCCCH | 25.44 | 22210691 | |
| 501 | Ubiquitination | KQWKAFTKMASAPAS HHHHHHHHHHCCCHH | 26.47 | 21890473 | |
| 504 | Phosphorylation | KAFTKMASAPASYGS HHHHHHHCCCHHCCC | 31.14 | 21406692 | |
| 508 | Phosphorylation | KMASAPASYGSTTTK HHHCCCHHCCCCCCC | 29.03 | 20068231 | |
| 509 | Phosphorylation | MASAPASYGSTTTKP HHCCCHHCCCCCCCC | 19.73 | 20068231 | |
| 511 | Phosphorylation | SAPASYGSTTTKPMG CCCHHCCCCCCCCCC | 17.85 | 21406692 | |
| 512 | Phosphorylation | APASYGSTTTKPMGL CCHHCCCCCCCCCCH | 33.84 | 21406692 | |
| 513 | Phosphorylation | PASYGSTTTKPMGLL CHHCCCCCCCCCCHH | 34.22 | 21406692 | |
| 514 | Phosphorylation | ASYGSTTTKPMGLLS HHCCCCCCCCCCHHH | 32.99 | 21406692 | |
| 515 | Ubiquitination | SYGSTTTKPMGLLSR HCCCCCCCCCCHHHH | 30.80 | 21906983 | |
| 521 | Phosphorylation | TKPMGLLSRVMNTGS CCCCCHHHHHHHCCC | 28.07 | 21406692 | |
| 526 | Phosphorylation | LLSRVMNTGSQFVME HHHHHHHCCCHHHHH | 21.80 | 24173317 | |
| 528 | Phosphorylation | SRVMNTGSQFVMEGV HHHHHCCCHHHHHHH | 20.57 | 17525332 | |
| 536 | Ubiquitination | QFVMEGVKNLVLKQQ HHHHHHHHHHHHHCC | 56.26 | 21906983 | |
| 536 | Acetylation | QFVMEGVKNLVLKQQ HHHHHHHHHHHHHCC | 56.26 | 30592183 | |
| 541 | Malonylation | GVKNLVLKQQNLPVT HHHHHHHHCCCCCHH | 42.21 | 26320211 | |
| 541 | Ubiquitination | GVKNLVLKQQNLPVT HHHHHHHHCCCCCHH | 42.21 | - | |
| 548 | Phosphorylation | KQQNLPVTRILDNLM HCCCCCHHHHHHHHH | 15.28 | 20068231 | |
| 555 | Sulfoxidation | TRILDNLMEMKSNPE HHHHHHHHHHHCCCC | 6.24 | 21406390 | |
| 558 | Ubiquitination | LDNLMEMKSNPETDD HHHHHHHHCCCCCCC | 33.50 | 2190698 | |
| 572 | Ubiquitination | DYRYFDPKMLRGNDS CCCCCCHHHHCCCCC | 53.03 | - | |
| 575 | Methylation | YFDPKMLRGNDSSVP CCCHHHHCCCCCCCC | 38.07 | 115493403 | |
| 637 | Phosphorylation | TQFIKQLSQLGQK-- HHHHHHHHHHCCC-- | 22.36 | 28857561 | |
| 642 | Ubiquitination | QLSQLGQK------- HHHHHCCC------- | 61.58 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SCFD1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SCFD1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SCFD1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ODO2_HUMAN | DLST | physical | 16169070 | |
| DKKL1_HUMAN | DKKL1 | physical | 19176879 | |
| KAT5_HUMAN | KAT5 | physical | 19176879 | |
| APBP2_HUMAN | APPBP2 | physical | 19176879 | |
| VPP1_HUMAN | ATP6V0A1 | physical | 22939629 | |
| SNP23_HUMAN | SNAP23 | physical | 22939629 | |
| VAMP2_HUMAN | VAMP2 | physical | 22939629 | |
| RM09_HUMAN | MRPL9 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-303, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-303, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-303, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-528, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, AND MASSSPECTROMETRY. | |